Millions in the United States are affected by diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD), both of which are leading causes of central vision loss. The introduction of several intravitreal therapies has changed the natural progression of DME and nAMD, making improvements in and restoration of visual acuity a reality for many patients. However, the frequency of intravitreal injections poses its own sort of burden on patients. The past year has introduced (and re-introduced) strategies to help alleviate this treatment burden, including new molecular targets, dosing strategies, and implantable devices. Listen as Dr. Arshad Khanani reviews the latest data on how to reduce the DME/nAMD treatment burden without compromising safety/efficacy.
Upon completion of this activity, participants should be better able to:
Managing Partner and Director, Clinical Research
Director, Fellowship
Vitreo-Retinal Diseases and Surgery
Sierra Eye Associates
Clinical Professor
University of Nevada, Reno School of Medicine
Reno, NV
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy.
Arshad M. Khanani, MD, MA, FASRS, has relevant financial relationships with AbbVie, ADARx Pharmaceutical, Adverum, Alcon, Alkeus, Allgenesis, Amgen, Annexon Biosciences, Appelis Pharmaceuticals, Ashvattha Therapeutics, Astellas, Aviceda Therapeutics, Beacon Therapeutics, Boehringer Ingelheim, Clearside Biomedical, Complement Therapeutics, 4DMT, Exegenesis, Eyepoint Pharmaceuticals, Fronterra Therapeutics, Genentech, Gyroscope Therapeutics, Harrow, i-Leumen Scientific, InFocus, Iveric Bio, Janssen Pharmaceuticals, Kodiac Sciences, Kriya Therapeutics, Kyowa Kirin, Merit, Neurotech, Nanoscope, Novartis, Ocular Therapeutix, Oculis, Ocuphire, Ocuterra, Ollin, Olive BioPharma, Opthea, Opus Genetics, Oxular, Oxurion, Perfuse, Ray Therapeutics, Recens Medical, Regeneron Pharmaceuticals, Regenxbio, Revive, RevOpsis, Roche, Samsung, Sanofi, Stealth Bio Therapeutics, Surrozen, Thea Pharma, Therini, Unity Biotechnology, Vanotech, Vial, ZipBio (Consultant); Aviceda, Adverum, Alexion, Annexon Biosciences, Apellis Pharmaceuticals, Astellas, Complemment Therapeutics, 4DMT, Eyepoint Pharmaceuticals, Exegenesis, Genentech, Gyroscope Therapeutics, Iveric Bio, Janssen, Kodiak, Kyowa Kirin, Neurotech, Ocular Therapeutix, Oxular, Roche, Sanofi, Vanotech (Researcher); Ashvattha, Aviceda Therapeutics, PolyPhotonix, Recens Medical, Perfuse, RevOpsis, Vial (Stock Options); Oculis, Ollin (Stock/Shareholder).
All of the relevant financial relationships listed for this individual have been mitigated according to RMEI policies.
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
RMEI Medical Education, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. A statement of credit will be available to print immediately. You must score 80% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected].
Users must:
There is no fee to participate.
COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED INTO A DRAWING
FOR A $100* AMAZON GIFT CARD!*
*The expense for this gift card is solely funded by RMEI Medical Education, LLC.
No supporter funding was used for the expense of this gift card.
Rules and Regulations
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
